5-[[trans-4-[4-(trifluoromethoxy)phenyl]cyclohexyl]oxy]-1H-1,2,3-triazole-4-carboxylic acid

Star0

DB18067InvestigationalSmall molecule

5-[[trans-4-[4-(trifluoromethoxy)phenyl]cyclohexyl]oxy]-1H-1,2,3-triazole-4-carboxylic acid: Overview.

Formula / weight: C₁₆H₁₆F₃N₃O₄ · 371.316 g/mol (avg)
Also known as: 5-((trans-4-(4-(trifluoromethoxy)phenyl)cyclohexyl)oxy)-1h-1,2,3-triazole-4-carboxylic acid · 5-[[trans-4-[(trifluoromethoxy)phenyl]cyclohexyl]oxy]-1H-1,2,3-triazole-4-carboxylic acid
Code names: BMN-255

Resolves to

Compound

UNIIWC82E7HRU5CAS2360927-98-4

Structure

InChIKeyUINBFJPVDKLYIY-HOMQSWHASA-NSMILESOC(=O)C1=C(NN=N1)O[C@H]1CC[C@@H](CC1)C1=CC=C(OC(F)(F)F)C=C1

What you can answer from here — as of April 23, 2025

1Clinical trialPhase, status and sponsor resolved per trial

Which companies are running trials of 5-[[trans-4-[4-(trifluoromethoxy)phenyl]cyclohexyl]oxy]-1H-1,2,3-triazole-4-carboxylic acid, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account